All News

A change Felder hopes to evoke is to get more cervical cancer survivors talking about the disease to help eliminate the stigma attached to having a below the belt cancer.

The identification of microsatellite status, tumor mutational burden and protein expression in colorectal cancer (CRC) tumors may lead to better outcomes in a subgroup of patients.

Patients with microsatellite instability-high (MSI-H) colorectal cancer may undergo a distinct pattern of clonal evolution, which in turn, would impact the use of targeted and immunologic therapies in these patients, according to study results presented at the 2018 Gastrointestinal Cancer Symposium.

When she was originally diagnosed, I knew nothing of palliative care. I had only heard about hospice, and the use of that word terrified me.

Lutathera (lutetium [177Lu] oxodotreotide) was approved for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) – a rare cancer that affects the pancreas and gastrointestinal tract.

Our lives are broken up after a loss, but eventually the pieces are put back together. The hard part is that the new pieces can make a totally different picture.

Patients previously treated for DNA mismatch repair (MMR)-deficient/microsatellite instability-high (MSI-H) metastatic colorectal cancer may have a new effective treatment option.

Throughout her life and especially in her fight against lung cancer, Mom set us an example in unconditional devotion, taught our family valuable life lessons and never lost her indomitable spirit.

Don't let the noise of other people's opinions distract you from making the right cancer treatment decision.

It's challenging to accept the physical limitations one may experience post-cancer, but changes to the body can pose real physical constraints.

Texas Rangers third-base coach Tony Beasley teams up with Fight CRC, sharing his journey into survivorship and inspiring others in their fight against cancer.

Even when a patient thinks they may have exhausted their very last treatment option, the Targeted Agent and Profiling Utilization Registry (TAPUR) Study is just the thing they may need.

While only time will tell if the Cancer Moonshot will spearhead a decade of progress in five years, it is indisputable that Vice President Biden has brought the urgency to curing cancer back into focus.

I'm still scuffling with cancer, but that won't prevent other health conditions from creeping up.

Daniel J. George, M.D., discusses the role of immunotherapy, its continued integration into standards of care and what else the future holds for the treatment of bladder cancer.

Two-time cancer survivor encourages newly diagnosed patients to keep hope.

Man’s best friend has joined the fight against cancer by significantly helping families of children undergoing treatment.

A little focus on intentions for the week can help fight off cancer blues and allow more time for taking care of yourself.

Treatments and surgeries are a personal choice. Patients should talk with doctors and other patients and survivors to determine what is best for them.

Clinical trials designed to evaluate the use of anti-cancer drugs for the treatment of cancer typically exclude patients whose disease has spread to the brain or CNS for a number of reasons, including the misperception that they are poor clinical trial candidates.

A sick stomach, to high-fever, chest pains and heart infection is just a learning experience for some doctors.

Why do some pediatric ALL survivors live the rest of their lives cancer-free, while others face secondary cancers or death?

We don’t need to move mountains, build a house or even clean out every closet in one day. Sometimes we just have to clean one shelf at a time, put one foot in front of the other and remind ourselves that is enough for today.

The scars breast cancer leaves on our bodies tell a story. What will yours say?

Today women face a plethora of options. Their tumors are tested for all kinds of differences that may tell them if chemotherapy will work and which drugs would work best. There are support groups and help for families that we didn’t have.

Two-time cancer survivor discusses the art of waiting, be it for treatments, rechecks or test results.

Safety net hospitals exist to offer care to vulnerable populations, such as those on Medicaid or who are uninsured. However, these patients still face barriers to care that affect survival outcomes.

The Food and Drug Administration (FDA) granted priority review to the combination use of Darzalex (daratumumab), Velcade (bortezomib), melphalan and prednisone for the treatment of newly diagnosed patients with multiple myeloma who are not eligible for autologous stem cell transplant (ACST).

Breast cancer survivor speculates about achieving health and wonders what "healthy" even means. Is the game rigged?

It's sometimes easy to think that our bodies have failed us, but we need all the help we can get.